The Biggest Psychedelic Legislation News Stories This Week – April 7
This week, there were mixed results in the push to legalize psychedelic substances. States across the US are rapidly pushing ahead while some bills are getting a push back.
This week, there were mixed results in the push to legalize psychedelic substances. States across the US are rapidly pushing ahead while some bills are getting a push back.
Three bills have been brought forward to legalize certain plants and fungi, facilitate the therapeutic use of psilocybin plus enable access to a prescription medicine containing MDMA.
Two somewhat popular methods of combining psychedelics are candy flipping and hippie flipping.
Welcome to this week’s roundup of noteworthy news regarding psychedelics….
Bay Staters for Natural Medicine, a grassroots community group with more than three thousand volunteers across New England, has worked with five city councils to pass measures decriminalizing psychedelic plants, including psilocybin mushrooms.
Well Do You Know Your Psychedelics? We’ve created 8 Funny Psychedelic Riddles so you can test the psychonaut in you.
Jessika Lagarde, the co-founder of Women on Psychedelics, explores how various psychoactive substances can treat mental health issues including depression, eating disorders, PTSD, and addiction.
In this episode, Dennis Walker speaks with Victor Mifsud about how a few MDMA experiences helped him have a temporary remission of his retinitis pigmentosa, a disease which has caused him to be legally blind.
Good news from the Australian Therapeutic Goods Administration, as they will now allow for the prescription of MDMA to treat post-traumatic stress disorder (PTSD), and psilocybin to combat treatment-resistant depression. This new classification is a step forward in providing relief with alternative treatments that have been proven effective.
Psychedelic therapy is growing in popularity, but clinical trials often overlooks the unique needs of diverse racial and ethnic populations
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.